Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166205 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Phase 3 study, sponsored by Ethicon Endo-Surgery.
- Completed
- Registry status
- Phase 3
- Development phase
- 276
- Enrollment target
NCT00166205 is a Phase 3 study that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 276 participants.
The verdict
NCT00166205, a Phase 3 study, has completed, sponsored by Ethicon Endo-Surgery.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 276 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Swedish Adjustable Gastric Band (SAGB) is safe, and effective in achieving weight loss in patients with Morbid Obesity.
Interventions
- DEVICE Swedish Adjustable Gastric Band
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166205
The ClinicalTrials.gov registry entry for NCT00166205 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Swedish Adjustable Gastric Band is the first listed.
NCT00166205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166205 about?
NCT00166205 is a clinical study titled "Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity". The purpose of this study is to determine whether the Swedish Adjustable Gastric Band (SAGB) is safe, and effective in achieving weight loss in patients with Morbid Obesity.
What is the current status of trial NCT00166205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 276 participants. The study started on 2003-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00166205?
The interventions under investigation include: Swedish Adjustable Gastric Band (DEVICE).
Who is sponsoring clinical trial NCT00166205?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.